Versor Investments LP Trims Stock Position in Humana Inc. $HUM

Versor Investments LP decreased its stake in Humana Inc. (NYSE:HUM) by 58.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,394 shares of the insurance provider’s stock after selling 3,398 shares during the period. Versor Investments LP’s holdings in Humana were worth $623,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Elevation Point Wealth Partners LLC acquired a new position in Humana in the second quarter valued at $32,000. Mather Group LLC. purchased a new stake in shares of Humana in the 3rd quarter valued at about $34,000. AlphaCore Capital LLC purchased a new stake in shares of Humana in the 2nd quarter valued at about $39,000. Private Wealth Management Group LLC boosted its position in shares of Humana by 47.5% in the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 48 shares during the period. Finally, SJS Investment Consulting Inc. grew its stake in Humana by 19,300.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock worth $50,000 after buying an additional 193 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Humana

Here are the key news stories impacting Humana this week:

• Positive Sentiment: Company forecasts ~25% Medicare Advantage membership growth for 2026, which could help top-line scale and market share. Humana outlines 25% Medicare Advantage membership growth for 2026
• Positive Sentiment: Revenue beat: Q4 revenue rose ~11% y/y, helped by CenterWell (value of care delivery assets), showing underlying growth even as profits weaken. Humana Incurs Q4 Loss, Revenues Up Y/Y on CenterWell Unit Strength
• Positive Sentiment: Market position: analysts and press note Humana could become the largest Medicare Advantage insurer by end-2026 as membership expands, which supports long-term strategic upside. Humana could end 2026 as the largest Medicare Advantage insurer
• Neutral Sentiment: Reported Q4 GAAP loss widened (net loss) but beat the adjusted EPS consensus by a small amount; investors are parsing GAAP vs. adjusted metrics. Humana Q4 results and call
• Neutral Sentiment: Management says it is prepared to adapt if 2027 Medicare Advantage rates remain flat — a tactical comment that may limit downside but doesn’t remove near-term margin pressure. Humana CEO says insurer is ready to adapt if 2027 MA rates stay flat
• Negative Sentiment: FY-2026 EPS guidance of $9.00 is materially below the street (~$12.03) — the primary driver of the stock selloff as investors reprice earnings power. Humana forecasts 2026 profit below estimates
• Negative Sentiment: Medicare Advantage margin pressure from rising medical costs, lower-quality (STAR) ratings and weaker investment income pushed a wider loss and prompted management to flag near-term profitability headwinds. Humana projects sharply lower earnings as Medicare membership surges
• Negative Sentiment: Market reaction: shares hit a 52-week low and analysts turned cautious after Humana followed peers with a disappointing 2026 outlook, increasing short-term downside risk. Humana Hits 52-Week Low After Weak Profit Outlook

Humana Price Performance

Shares of NYSE:HUM opened at $175.35 on Thursday. Humana Inc. has a 52 week low of $169.61 and a 52 week high of $315.35. The company has a 50-day moving average price of $247.61 and a 200 day moving average price of $261.75. The company has a market cap of $21.09 billion, a P/E ratio of 16.43, a PEG ratio of 1.50 and a beta of 0.44. The company has a quick ratio of 2.02, a current ratio of 2.02 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. Humana had a return on equity of 12.86% and a net margin of 1.02%.The firm had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $32.08 billion. During the same period in the previous year, the business earned ($2.16) earnings per share. The company’s revenue for the quarter was up 11.3% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on HUM shares. Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a research note on Thursday, January 22nd. Wells Fargo & Company downgraded shares of Humana from an “overweight” rating to a “cautious” rating in a research report on Wednesday, January 7th. Zacks Research cut shares of Humana from a “hold” rating to a “strong sell” rating in a research note on Thursday, January 1st. Barclays reissued an “underperformer” rating on shares of Humana in a research report on Monday, January 5th. Finally, Truist Financial dropped their price objective on shares of Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a research note on Monday, November 10th. Seven research analysts have rated the stock with a Buy rating, ten have given a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $282.32.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.